
Retatrutide Before FDA Approval? Lilly Just Changed the Conversation
Notas del episodio
Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.

Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.